DocGo Inc.
HealthcareNASDAQ:DCGO · NASDAQ Capital Market
+$0.01 today
Vol 0.35M · Avg 0.99M
Balance Sheet
Inspect the capital base behind the business
Review assets, liabilities, equity, cash, and debt to judge whether the company has the financial position to support future returns.
Balance Sheet
Assets, liabilities & equity
| Cash & Equivalents | $35.7M |
| Receivables | $94.0M |
| Other Current | $8.5M |
| Total Current Assets | $138.2M |
| PP&E (Net) | $42.0M |
| Intangible Assets | $644.1K |
| Long-term Investments | $24.3M |
| Tax Assets | $814.0K |
| Other Non-current | $3.3M |
| Total Non-current Assets | $71.1M |
| Total Assets | $209.2M |
Analysis
Selected assets total $209.2M for Latest. The largest visible component is Receivables at $94.0M, about 44.9% of the tab total. Use the mix to judge balance sheet concentration, liquidity, leverage, and how much of book value is supported by tangible operating assets.
Balance Sheet
Annual data · 5 periods
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $51.0M -42.8% | $89.2M +50.5% | $59.3M -62.3% | $157.3M -10.4% | $175.5M | $1.0B | $841.8M | $673.8M |
| Short-term Investments | $0 | $0 | $0 | $0 | $0 | -$1.6B | $445.6M | $378.4M |
| Net Receivables | $92.9M -56.0% | $210.9M -19.5% | $262.1M +154.5% | $103.0M +31.4% | $78.4M | $533.8M | $399.4M | -$1.7B |
| Inventory | $0 | $0 | $0 -100.0% | $4.5M | $0 | $641.6M | $328.0M | $316.8M |
| Other Current Assets | $3.7M -14.9% | $4.3M -75.2% | $17.5M +179.1% | $6.3M | $0 | $1.5B | $966.4M | $764.8M |
| Total Current Assets | $152.4M -49.9% | $304.5M -10.1% | $338.9M +25.0% | $271.1M +5.9% | $256.0M | $12.5B | $10.5B | $5.5B |
| Property, Plant & Equipment (Net) | $43.5M +3.1% | $42.2M +9.8% | $38.4M -2.4% | $39.4M +50.1% | $26.2M | $1.2B | $1.5B | $687.8M |
| Goodwill | $0 -100.0% | $47.4M -0.2% | $47.5M +22.2% | $38.9M +347.8% | $8.7M | $925.8M | $466.6M | $309.8M |
| Intangible Assets | $0 -100.0% | $25.7M -31.7% | $37.7M +64.1% | $23.0M +115.1% | $10.7M | $568.8M | $860.0M | $1.5B |
| Long-term Investments | $0 -100.0% | $5.5M +902.2% | $553.6K -7.4% | $598.0K +1.5% | $589.1K | $524.0M | -$1.5B | $860.0M |
| Tax Assets | $538.9K -93.6% | $8.4M -29.2% | $11.9M +19.4% | $10.0M | $0 | $1.5B | $1.4B | $1.4B |
| Other Non-current Assets | $20.7M -5.3% | $21.8M +40.8% | $15.5M +49.0% | $10.4M +40.9% | $7.4M | $1.4B | $1.0B | $679.4M |
| Total Non-current Assets | $64.7M -57.2% | $151.1M -0.3% | $151.6M +24.0% | $122.2M +128.1% | $53.6M | -$15.3B | $14.8B | $11.3B |
| Total Assets | $217.1M -52.4% | $455.6M -7.1% | $490.5M +24.7% | $393.3M +27.0% | $309.6M | $13.3B | $11.9B | $10.6B |
| Account Payables | $11.1M -60.8% | $28.4M +43.0% | $19.8M -8.1% | $21.6M +36.3% | $15.8M | $1.3B | -$1.5B | $1.4B |
| Short-term Debt | $51.7K -99.8% | $30.0M +19.9% | $25.0M +3664.1% | $664.9K +6.2% | $626.3K | -$1.6B | -$1.6B | $326.6M |
| Tax Payables | $0 | $0 | $0 | $0 | $0 | $574.4M | -$1.5B | $1.4B |
| Deferred Revenue | $0 | $0 | $0 | $0 | $0 | -$1.6B | $374.2M | $542.2M |
| Other Current Liabilities | $23.9M -12.7% | $27.4M -31.2% | $39.8M -19.4% | $49.4M +315.5% | $11.9M | $1.1B | $1.5B | $493.2M |
| Total Current Liabilities | $67.5M -44.6% | $121.8M -28.4% | $170.1M +69.8% | $100.2M +73.1% | $57.9M | $6.0B | $10.1B | $14.3B |
| Long-term Debt | $183.8K +3425.3% | $5.2K -87.5% | $41.6K -96.6% | $1.2M -5.1% | $1.3M | $1.3B | $438.6M | $1.3B |
| Deferred Tax Liabilities | $0 | $0 | $0 | $0 | $0 | $746.6M | $612.2M | $477.8M |
| Deferred Revenue (Non-current) | $0 | $0 | $0 | $0 | $0 | -$1.6B | $715.8M | $1.3B |
| Other Non-current Liabilities | $4.8M | $0 | $0 | $0 -100.0% | $13.5M | $489.0M | $1.1B | -$1.5B |
| Total Non-current Liabilities | $23.7M +27.4% | $18.6M +22.9% | $15.2M +6.8% | $14.2M -42.5% | $24.7M | $3.9B | $7.5B | $14.1B |
| Total Liabilities | $91.2M -35.0% | $140.4M -24.2% | $185.3M +62.0% | $114.4M +38.5% | $82.5M | $14.7B | $3.7B | $9.6B |
| Common Stock | $9.9K -3.2% | $10.2K -2.1% | $10.4K +1.6% | $10.2K +2.3% | $10.0K | $651.4M | $517.0M | $382.6M |
| Retained Earnings | -$183.8M -13008.4% | -$1.4M +93.4% | -$21.4M +26.2% | -$29.0M +54.4% | -$63.6M | -$1.6B | $519.8M | $1.1B |
| Accumulated OCI | $2.4M +95.4% | $1.2M -17.7% | $1.5M +100.3% | $741.2K +2380.6% | -$32.5K | $393.8M | $550.6M | $707.4M |
| Other Stockholders Equity | $0 | $0 | $0 | $0 | $0 | $351.8M | -$1.6B | $1.5B |
| Minority Interest | -$18.1M -216.1% | -$5.7M -231.1% | $4.4M -23.2% | $5.7M -23.8% | $7.5M | $1.4B | $337.8M | $931.4M |
| Total Equity | $125.9M -60.1% | $315.2M +3.3% | $305.2M +9.4% | $278.9M +22.8% | $227.1M | $9.1B | $7.7B | $3.3B |
| Total Debt | $29.2M -49.0% | $57.2M +23.0% | $46.5M +133.5% | $19.9M +20.6% | $16.5M | $724.2M | $410.6M | $399.4M |
| Net Debt | -$21.8M +31.9% | -$32.1M -150.6% | -$12.8M +90.7% | -$137.4M +13.6% | -$159.0M | $389.6M | $501.6M | $311.2M |
Older periods hidden.
Sign in to unlockCompetitors
Peer companies in the same sector
Immix Biopharma, Inc.
NASDAQ:IMMX
$459.70M
Prelude Therapeutics Incorporated
NASDAQ:PRLD
$352.45M
Ovid Therapeutics Inc.
NASDAQ:OVID
$303.33M
MacroGenics, Inc.
NASDAQ:MGNX
$251.71M
Quipt Home Medical Corp.
QIPT
$162.30M
AVITA Medical, Inc.
NASDAQ:RCEL
$97.14M
Coya Therapeutics, Inc.
NASDAQ:COYA
$86.31M
Microbot Medical Inc.
NASDAQ:MBOT
$81.12M
Vivani Medical, Inc.
NASDAQ:VANI
$64.99M
InspireMD, Inc.
NSPR
$34.19M
SEC Filings
Recent regulatory filings
No filings found.
How much cash does DCGO have?
DocGo Inc. (DCGO) reported $51.02M in cash and equivalents in fiscal 2025.
How much debt does DCGO carry?
DocGo Inc. (DCGO) reported $29.18M of total debt, with net debt of -$21,840,863.00.
Explore More
Continue the stock analysis
Jump to another research area for this company.